In Vitro Diagnostic Industry in China - Diagnosis of Blood and Body Fluids XVI

3.3 From Decentralization to Centralization

As one of the segments of in vitro diagnostics, the blood coagulation testing is faster than other industries in terms of the growth rate. In the capital market, there are frequent mergers and acquisitions in the coagulation diagnosis industry. Mindray, BSBE, Maccura, and other listed companies of IVD started their business in the coagulation; and Succeeder, whose main business is blood coagulation, has also been listed. The R&D and production capacity and capital advantages of leading IVD companies will inevitably promote the centralization of the coagulation market, and the demand for mergers and acquisitions is strong. On the one hand, the mergers and acquisitions of these listed companies can increase the coverage of testing business, enhance the ability to negotiate prices of the downstream of the industry, and obtain more comprehensive business coverage, consolidate and improve their own business strength, and increase overall competitiveness. On the other hand, with the introduction of a series of national policies and the continuous improvement of the regulatory system, some small enterprises will gradually withdraw from the field under the pressure of competition and supervision, while the large leading enterprises will dominate the market and greatly increase the degree of concentration of the blood coagulation industry, ultimately prompting the development of the entire industry.

Last: In Vitro Diagnostic Industry in China - Diagnosis of Blood and Body Fluids XV